Karyopharm Therapeutics Inc. (54) | Bonus & Incentive Agreements (15)
Recent Contracts
-
Form of Restricted Stock Unit Agreement under 2022 Equity Incentive Plan
(Filed With SEC on August 4, 2022)
-
Form of Incentive Stock Option Agreement under 2022 Equity Incentive Plan
(Filed With SEC on August 4, 2022)
-
Form of Incentive Stock Option Agreement under the 2022 Israeli Equity Incentive Sub Plan to the 2022 Equity Incentive Plan
(Filed With SEC on August 4, 2022)
-
Form of Restricted Stock Unit Agreement under the 2022 Israel Equity Incentive Sub Plan to the 2022 Equity Incentive Plan
(Filed With SEC on August 4, 2022)
-
2022 Inducement Stock Incentive Plan
(Filed With SEC on March 1, 2022)
-
Form of Restricted Stock Unit Agreement under 2013 Stock Incentive Plan adopted January 24, 2022
(Filed With SEC on March 1, 2022)
-
Form of Nonstatutory Stock Option Agreement under 2022 Inducement Stock Incentive Plan
(Filed With SEC on March 1, 2022)
-
Form of Restricted Stock Unit Agreement under 2022 Inducement Stock Incentive Plan
(Filed With SEC on March 1, 2022)
-
Form of Incentive Stock Option Agreement under 2013 Stock Incentive Plan adopted August 25, 2020
(Filed With SEC on November 2, 2020)
-
Form of Nonstatutory Stock Option Agreement under 2013 Stock Incentive Plan adopted August 25, 2020
(Filed With SEC on November 2, 2020)
-
Form of Restricted Stock Unit Agreement under 2013 Stock Incentive Plan adopted August 25, 2020
(Filed With SEC on November 2, 2020)
-
2020 Israeli Equity Incentive Sub Plan to the 2013 Stock Incentive Plan
(Filed With SEC on November 2, 2020)
-
Form of Option Agreement under 2020 Israeli Equity Incentive Sub Plan to the 2013 Stock Incentive Plan
(Filed With SEC on November 2, 2020)
-
Form of Restricted Stock Unit Agreement under 2020 Israeli Equity Incentive Sub Plan to the 2013 Stock Incentive Plan
(Filed With SEC on November 2, 2020)
-
Karyopharm Therapeutics Inc. Annual Bonus Plan
(Filed With SEC on August 6, 2019)